Mariner’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,506
Closed -$455K 3671
2025
Q2
$455K Sell
3,506
-705
-17% -$102K ﹤0.01% 2401
2025
Q1
$671K Sell
4,211
-626
-13% -$113K ﹤0.01% 1962
2024
Q4
$897K Buy
4,837
+77
+2% +$14.9K ﹤0.01% 1738
2024
Q3
$1M Sell
4,760
-698
-13% -$121K ﹤0.01% 1600
2024
Q2
$730K Buy
5,458
+971
+22% +$184K ﹤0.01% 1743
2024
Q1
$964K Sell
4,487
-664
-13% -$130K ﹤0.01% 1524
2023
Q4
$1.05M Buy
5,151
+938
+22% +$152K ﹤0.01% 1398
2023
Q3
$836K Sell
4,213
-120
-3% -$30.3K ﹤0.01% 1423
2023
Q2
$1.41M Buy
4,333
+1
+0% +$286 ﹤0.01% 1123
2023
Q1
$1.01M Buy
4,332
+3,072
+244% +$777K ﹤0.01% 1266
2022
Q4
$317K Buy
1,260
+130
+12% +$27.7K ﹤0.01% 1979
2022
Q3
$200K Buy
+1,130
New +$227K ﹤0.01% 2061

Other funds holding INSP

Mariner's INSP Position: Q3 2025 in Review

Mariner sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 3,506 shares — an estimated $455K sold.

Mariner first reported a position in INSP in Q3 2022 and held it in 12 quarters. The position peaked at $1.41M in Q2 2023. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Mariner reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Mariner sold 3,506 Inspire Medical Systems shares in Q3 2025, an estimated $455K.
  • Mariner first reported a position in Inspire Medical Systems in Q3 2022 and held it in 12 quarters.
  • Mariner's Inspire Medical Systems position peaked at $1.41M in Q2 2023.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Mariner's 13F filing for Q3 2025, filed 14 Nov 2025.